The Global Vitiligo Treatment Market is likely to gain impetus from an ever rising demand for innovative and modern treatment options for vitiligo. According to Fortune Business Insights, titled, “Vitiligo Treatment: Global Market Analysis, Insights and Forecast, 2019-2026,” the global vitiligo treatment market was valued at US$ 1,243.8 Mn in 2018. The market is projected to reach US$ 1,944.5 Mn by 2026, exhibiting a CAGR of 5.8% in the forecast period.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/vitiligo-treatment-market-100580

Some of the Main Key Players Covered in the Report

• Incyte Corporation
• Astellas Pharma Inc.
• Bausch Health Companies Inc.
• Baxter International Inc.
• Pfizer Inc.
• STRATA Skin Sciences
• Reddy’s Laboratories Ltd.

In terms of treatment, the global vitiligo treatment market is grouped into topical treatment, surgical procedures, light therapy, and others. Amongst these, the topical treatment segment had held majority of the vitiligo treatment market share. This is because of the increasing patient pool, need for numerous treatment methods for vitiligo, and an increasing number of research and development activities. However, lack of awareness regarding the available vitiligo treatment and reduction in the diagnosis rate may hamper the vitiligo treatment market growth.

Increasing Number of Vitiligo Patients to Favor Growth in Asia Pacific

The global vitiligo treatment market is geographically divided into North America, Latin America, the Middle East and Africa, Europe, and Asia Pacific. Amongst these, in Asia Pacific, India, China, and the other Southeast Asian countries have been witnessing huge patient pools of vitiligo.

This has further resulted in an urgent requirement for effective treatment options available of vitiligo. The markets of Latin America and the Middle East and Africa, on the other hand are expected witness notable grow in the near future. This is because darker skinned individuals who suffer from vitiligo are demanding for modern methods of treatment that would help the condition become less noticeable on them.

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/vitiligo-treatment-market-100580

Key Players Focus on Effective Medicine Launch to Strengthen Market Position 

Incyte Corporation, a pharmaceutical company, based in the U.S., announced the result of its dose-ranging, randomized, vehicle-controlled, and double-blind Phase 2 study evaluating ruxolitinib cream, an anti-inflammatory, nonsteroidal, and JAK inhibitor therapy in patients with vitiligo between the age group of 18 to 75 years of age. The results were out after 24 weeks.

The study met its primary goal and treated many patients with the help of ruxolitinib cream for 24 weeks. The results were presented at the 24^th World Congress of Dermatology in Italy. The positive result supports the potential of ruxolitinib cream in providing novel treatment for chronic autoimmune disease.

The global temperature monitoring system market size is projected to reach USD 3.00 billion by 2027, exhibiting a CAGR of 11.2% during the forecast period. Surging number of COVID-19 cases worldwide will spike the adoption of temperature monitoring devices, shares Fortune Business Insights™ in its report, titled “Temperature Monitoring System Market Size, Share & COVID-19 Impact Analysis, By Product (Analog Temperature Monitoring Devices & Digital Temperature Monitoring Devices), By Type (Contact & Non-Contact) By End User (Healthcare Facilities, Home Care Settings, and Others), and Regional Forecast, 2020-2027”.

According to the World Health Organization (WHO), as of August 3, 2020, global coronavirus cases stood at 17,918,582, with the reported deaths at 686,703. The COVID-19 infection has been found to spread not only through contact and fomites but recent studies have also shown that it can be transmitted through air. As a result, doctors, physicians, and other healthcare workers are avoiding being in close proximity to patients. This has created a huge demand for remote, sensor-based thermometers that can check and monitor temperatures from a distance, thus preventing spread of the infection among frontline workers. Moreover, security officials at public places are also equipped with these devices to prevent the entry of any infected persons in such spaces.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/temperature-monitoring-systems-market-102013

List of Companies Profiled in this Market Report:

• Koninklijke Philips N.V. (Netherlands)
• Masimo (S.)
• Omron Healthcare (Japan)
• Geratherm (Germany)
• Braun Healthcare (Germany)
• A&D Company Ltd. (Japan)
• Toshiba Inc. (Japan)
• 3M (U.S.)
• Exergen Corporation (U.S.)
• Other Players

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: 

https://www.fortunebusinessinsights.com/temperature-monitoring-systems-market-102013

Market Restraint

Fears of Mercury Poisoning May Inhibit Product Adoption

A major hurdle stalling the temperature monitoring system market growth is the health risks associated with mercury poisoning. Conventional thermometers are filled with mercury because it is the only metal that remains liquid at room temperature and expands at the slightest change in temperature. Thus, mercury-based thermometers can immediately show elevated body temperature. However, despite its effectiveness, breaking of these devices and the resultant mercury spillage is a very real threat that raises understandable concerns among patients. The WHO states that exposure to mercury can have toxic consequences for the digestive, nervous, and immune systems, lungs, eyes, kidneys, and skin. The dangers are even more pronounced in young infants and particularly detrimental for pregnant women. As a result, digital temperature monitoring systems are being widely adopted by health professionals and even by households around the world to prevent exposure to mercury.

Regional Insights

North America to Chart Strong Growth Trajectory; Asia Pacific to Unleash Untapped Potential

North America, with a market size of USD 558.2 million in 2019, is expected to dominate the temperature monitoring system market share during the forecast period. The primary reason for the sustained dominance of the region is the rapid adoption of advanced healthcare technologies by hospitals and clinics. In addition to this, the on-going coronavirus pandemic, which has affected 4.8 million and killed 158,000 Americans, is further surging the demand for digital thermometers in the region.

Escalating number of COVID cases in India and China is fueling the demand for temperature monitoring systems in Asia Pacific. Besides this, global medical devices companies are gaining ground in the Asia Pacific market by aligning their growth strategies with the evolving health infrastructure in the region.

The global sleep apnea treatment devices market size is set to touch USD 8.97 billion by 2026, exhibiting a CAGR of 8.2% during the forecast period. Steadily climbing demand for sleep apnea devices, stemming from a consistent spread in the prevalence of sleep apnea, will be a major growth driver for this market, shares Fortune Business Insights™ in its new report, titled “Sleep Apnea Treatment Devices Market Size, Share & Industry Analysis, By Device Type (Positive Airway Pressure (PAP) Devices, Oral Appliances, Masks & Accessories, and Others), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/sleep-apnea-treatment-devices-market-102694

List of Players Covered in the Report:

• Braebon Medical Corporation
• Glidewell
• Oventus
• Fisher & Paykel Healthcare Limited
• ResMed
• DeVilbiss Healthcare
• BMC Medical Co., Ltd.
• SomnoMed
• Koninklijke Philips N.V.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/sleep-apnea-treatment-devices-market-102694

A study published in the medical journal Lancet in 2019 found that nearly 1 billion people worldwide suffer from Obstructive Sleep Apnea (OSA). Regionally, too, the statistics conform to the global trends. For instance, the European Respiratory Society estimates that 13% to 32% of the geriatric population in Europe suffer from sleep apnea. As a result, the demand for sleep apnea treatment is escalating and driving the sleep apnea treatment devices market trends. Furthermore, the incidence of OSA is spiking owing to the rising prevalence of obesity, the most common cause for interrupted sleep, which according to the World Health Organization, presently affects close to 650 million adults worldwide.

Regional Analysis

Availability of Advanced Treatment Options to Propel the Market in North America

With a market size of USD 2.35 billion in 2018, North America is poised to dominate the sleep apnea treatment devices market share during the forecast period. The key factors augmenting this regional market include wide availability and high adoption of advanced products, along with growing prevalence of sleep disorders among the populace. In addition to this, supportive health insurance and reimbursement policies are further fueling the uptake of these devices in the region.

In Asia-Pacific, the major driving force for the market is the rising demand for sleep apnea therapies in Japan and the presence of a large, underpenetrated market in the rest of the region. These factors are expected to aid Asia-Pacific to register a considerable CAGR in the upcoming years.

The global cosmetic surgery market is likely to gain traction from the ever-increasing number of patients undergoing procedures, such as chin augmentation, breast reduction, and breast augmentation. The American Society for Aesthetic Plastic Surgery (ASAPS) declared that in 2018, breast reduction (18%) and chin augmentation (20%) were two of the most popular surgical procedures in the U.S. This information is given by Fortune Business Insights™ in a recent report, titled, “Cosmetic Surgery Market Size, Share & Industry Analysis, By Type (Surgical Procedures, and Non-Surgical Procedures), By Gender (Males, and Females), By End User (Spas & Cosmetic Surgery Centers, and Hospitals & Specialty Clinics), and Regional Forecast, 2019-2026.” The report further states that the cosmetic surgery market size was USD 50.67 billion in 2018 and is projected to reach USD 66.96 billion by 2026, exhibiting a CAGR of 3.6% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/cosmetic-surgery-market-102628

Fortune Business Insights™ lists out some of the most reputed companies present in the aesthetic surgery market. They are as follows:

• TETIK
• Westlake Dermatology
• Long Island Plastic Surgical Group, P.C.
• ALLERGAN
• Merz Pharma
• Galderma Laboratories
• Cleveland Clinic
• Other key market players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cosmetic-surgery-market-102628

High Demand for Dermal Fillers Procedure to Accelerate Non-surgical Procedure Segment

In terms of procedure, the market is divided into non-surgical and surgical procedures. Amongst these, in 2018, the surgical procedures segment was in the leading position in the market. Although the number of surgical procedures is much lower than non-surgical procedures across the globe, expensive nature of the former is one of the main factors responsible for high share of the segment. Eyelid surgery, liposuction, and breast augmentation were the top surgical procedures that were performed the most in 2018.

The non-surgical procedures segment, on the other hand, is set to exhibit considerable growth owing to the rising number of patients undergoing dermal and injectable filler procedures around the world. Hyaluronic acid and botulinum toxin were two of the dominating fields in this segment in 2018. Development of new dermal fillers equipped with advanced features would aid growth of this segment. 

Regional Analysis-

Expansion of Medical Tourism to Favor Growth in Asia Pacific & Latin America

Geographically, the market is segregated into Latin America, Europe, the Middle East and Africa, North America, and Asia Pacific. Out of these, in 2018, North America generated USD 15.43 billion in terms of cosmetic surgery market revenue. This growth is attributable to the increasing number of surgical procedures performed in the U.S. The International Society of Aesthetic and Plastic Surgeons (ISAPS) stated that in 2018, approximately 4.3 million cosmetic procedures were performed in this country alone. It is combined with the rising per capita expenditure of the populaces in North America. Asia Pacific and Latin America are set to grow considerably in the forthcoming years fueled by the expansion of medical tourism in both these regions.

The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year, more than 300,000 adults belonging to the age group of 65 years and above are estimated to be hospitalized for hip fractures. Besides, around 30% of seniors fall per year. It is further leading to higher number of orthopedic injuries. Fortune Business Insights™ published this information in a recent study, titled, “Orthopedic Devices Market Size, Share & Industry Analysis, By Type (Joint Reconstruction Devices, Spinal Devices, Trauma Devices, Dental Implants, Orthobiologic Devices, Arthroscopy Devices, and Others), By End User (Hospitals, Orthopedic Clinic, Ambulatory Surgical Centers, and Others), and Regional Forecast, 2019-2026.” The study further mentions that the orthopedic devices market size stood at USD 51.33 billion in 2018 and is projected to reach USD 71.67 billion by 2026, thereby exhibiting a CAGR of 4.3% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/orthopedic-devices-market-102586

Fortune Business Insights™ presents a list of all the companies operating in the orthopedic medical devices market. They are as follows:

• Smith & Nephew
• Stryker
• Zimmer Biomet
• Medical Devices Business Services, Inc. (Johnson & Johnson)
• NuVasive, Inc.
• Medtronic
• Integra LifeSciences
• Wright Medical Group N.V.
• Össur Corporate
• Globus Medical
• Other prominent players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/orthopedic-devices-market-102586

Drivers & Restraints-

Rising Prevalence of Musculoskeletal Diseases to Drive Growth

The American Academy of Orthopedic Surgeons, a provider of educational programs for allied health professionals and orthopaedic surgeons, published a report that affirms that every year in the Unites States alone, approximately 6.8 million patients suffering from several orthopedic injuries come to medical attention. It proves that the rising prevalence of orthopedic injuries and musculoskeletal diseases is further resulting in agonizing physical pain and limited mobility. It is expected to propel the orthopedic devices market growth during the forthcoming years. However, the surgical procedure is very expensive in nature. It may hamper the growth of the market.

Segment-

Joint Reconstruction Segment to Lead Backed by Increasing Number of Surgical Procedures

Based on type, the market is grouped into joint reconstruction devices, dental implants, trauma devices, spinal devices, orthobiologic devices, arthroscopy devices, trauma devices, and others. Out of these, in 2018, the joint reconstruction segment held 35.8% in terms of orthopedic devices market share and is anticipated to lead the market throughout the forecast period. This growth is attributable to the rising number of procedures, namely, extrementies and shoulder reconstructions, hip and knee replacements, and other similar procedures associated with joints. The arthroscopy devices segment is likely to expand at fast pace owing to the increasing emergence of novel products and upsurging cases of soft tissue injuries related to sports.

The global cancer biomarkers market size is forecast to reach USD 48.20 billion by 2026 on account of the increasing popularity of personalized treatment for cancer worldwide. Biomarkers help to detect cancer at an early stage and facilitate noninvasive diagnosis at high-speed by utilizing different proteomic and genomic markers. As per a recently published report by Fortune Business insights™ titled, “Cancer Biomarkers Market Size, Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer And Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026,” the market size was USD 18.94 billion in 2018 and will exhibit a CAGR of 12.4% between 2019 and 2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/cancer-biomarkers-market-100630

List of Key Cancer Biomarker Market Manufacturers:

• Myriad RBM
• Abbott
• Hoffmann-La Roche Ltd.
• BioVision Inc.
• Thermo Fisher Scientific
• R&D System
• Bio-Rad Laboratories, Inc.
• Sino Biological Inc.
• CENTOGENE N.V.
• Sino Biological Inc.
• Axon Medchem

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cancer-biomarkers-market-100630

Report Highlights

The report offers a comprehensive overview of the market and its prime growth trajectories, such as drivers, restraints, challenges, and opportunities. It throws light on recent oncology biomarker market trends, key industry developments, and other interesting insights. The report emphasizes on the table of segmentation based on factors such as cancer type, biomarker type, end user, and geography. The report discusses the list of players operating in the market and the prime strategies adopted by them to gain a competitive edge in the market. For more information on the report, log on to the company website.

Market Drivers

Rise in Prevalence of Cancer Worldwide to Augment Growth

The increasing prevalence of cancer is a prime factor boosting the cancer biomarkers market growth. In addition to this, the market is also witnessing a significant rise on account of the growing demand for drug discovery and development for various cancer types. Additionally, many pharmaceutical companies are investing massive amounts into research and development of novel biomarkers for cancer therapeutics. Moreover, many clinical trials and pipeline studies are currently heading towards the end stages of development, and their market entry is likely to attract high cancer biomarkers market revenue in the coming years.

According to a report published by Fortune Business Insights, titled, “Autism Spectrum Disorder Therapeutics Market: Global Market Analysis, Insights and Forecast, 2018-2026,” the global market is likely to reach US$ 4,612.1 Mn by 2026 owing to the rising incidence of autism spectrum disorder worldwide. The report provides valuable insights into the global market trends and factors that are directly affecting the growth of the market. As per the report, the global autism spectrum disorder therapeutics market was worth US$ 3,293.0 Mn in 2018. Considering the increasing awareness programs regarding this particular disorder and less availability of treatment options, the global market is expected to rise at a moderate CAGR of 4.3% during the forecast period (2019-2026).

The report further states that the number of children diagnosed with autism is increasing day by day across the globe. This, combined with favorable reimbursement scenario, will increase the demand for applied behavioral analysis therapies. Such therapies aid in improving learning and physical disabilities in autistic children. Furthermore, FDA approvals of numerous medicines that are used to manage autism spectrum disorder are expected to propel the global autism spectrum disorder therapeutics market during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207

Key Players Operating in The Autism Spectrum Disorder Therapeutics Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Applied Behavior Consultants,
• Allergan,
• Pfizer Inc.,
• Q BioMed Inc,
• Fusion Autism Center,
• AstraZeneca,
• Hopebridge, LLC.,
• Johnson & Johnson Services, Inc.,
• Behavior Innovations,
• Eli Lilly and Company,
• Otsuka Holdings Co. Ltd.,
• other prominent market players.

Autistic Disorder Segment to Witness Growth Owing to the Rising Prevalence of the Disease

The global autism spectrum disorder therapeutics market is grouped into drug therapy and communication and behavioral therapy in terms of treatment type. Amongst these, the communication and behavioral therapy segment was in the leading position in the global market. Fortune Business Insights predicts that it will retain its position throughout the forecast period. In terms of type, the autism spectrum disorder therapeutics market is classified into Asperger syndrome, autistic disorder, pervasive development disorder, and others. Out of these, the autistic disorder segment procured the highest autism spectrum disorder therapeutics market share in the year 2018. It is anticipated to witness significant growth in the coming years. This growth is attributed to the increasing prevalence of this disorder.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/autism-spectrum-disorder-therapeutics-market-101207

Detailed Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Prevalence of Autism Spectrum Disorder for Key Countries/Region
   • Recent Industry Developments Such As Partnerships, Mergers, & Acquisitions
   • Regulatory Framework by Key Countries
   • Global Reimbursement Scenario and Economic Cost Burden for the Treatment of Autism Spectrum Disorder by Key Countries/Region
5. Global Autism Spectrum Disorder Therapeutics Market Analysis, Insights and Forecast, 2015-2026
   • Key Findings / Summary
   • Market Analysis, Insights and Forecast – By Type
     • Autistic Disorder
     • Asperger Syndrome
     • Pervasive Developmental Disorder
     • Others
   • Market Analysis, Insights and Forecast – By Treatment Type
     • Communication & Behavioral Therapies
       • Applied behavior analysis (ABA)
       • Speech & Language Therapy
       • Occupational Therapy

The global Nebulizer market size is projected to reach USD 1,778.8 million by 2027, exhibiting a CAGR of 8.1% during the forecast period. Increasing prevalence of respiratory disorders around the world will be the prime growth propeller for this market, shares Fortune Business Insights™ in its new report, titled “Nebulizer Market Size, Share & COVID-19 Impact Analysis, By Type (Jet Nebulizer, Ultrasonic Nebulizer, and Mesh Nebulizer) By Modality (Portable, and Table-top) By End User (Hospitals, Clinics, and Homecare Settings), and Regional Forecast, 2020-2027”.

The World Health Organization (WHO) states that respiratory diseases are the foremost cause of death and disability worldwide. According to its estimates, chronic obstructive pulmonary disorder (COPD) afflicts around 65 million and kills 3 million people every year. Similarly, pneumonia also kills millions of people annually and is the leading cause of mortality among children under 5 years of age. Furthermore, WHO data indicates that lung cancer is the deadliest cancer, killing 1.6 million people every year. Nebulizer play a key role in managing these chronic and potentially fatal lung disorders and as the incidence of these disorders grows, the demand for Nebulizer will continue to surge.

Request a Sample Copy of the Research Report:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nebulizers-market-100707

The report states that the market value was at USD 909.7 million in 2019. Its other highlights include:

• Valuable insights into the key market drivers, trends, and restraints;
• Exhaustive analysis of the upcoming market opportunities;
• In-depth examination of the impact of the COVID-19 outbreak on the market; and
• Comprehensive study of the regional prospects and competitive dynamics influencing the market.

An Overview of the Impact of COVID-19 on this Market:

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

To get the short-term and long-term impact of COVID-19 on this Market.

Please visit:https://www.fortunebusinessinsights.com/industry-reports/nebulizers-market-100707

Market Opportunity

Rapid Transmission of the COVID-19 Infection to Create Immediate Growth Opportunities

The SARS-CoV-2 infection attacks the respiratory tract and lungs, causing shortness of breath, acute breathing problems, and pneumonia, along with a persistent fever and cough. People with preexisting lung disorders such as asthma are at high risk of contracting the COVID-19 infection. According to the Centers for Disease Control and Prevention (CDC), asthma patients are highly recommended to carry inhalers or portable Nebulizer with them as these devices can efficiently open the lungs and allow them to function normally. In this scenario, the uptake of inhalable drug delivery devices is likely to spike and favor the Nebulizer market growth. The only worry with these devices, as pointed out by the Asthma and Allergy Foundation of America, is their potential to transmit the infection among patients as well as healthcare workers, especially in healthcare facilities. If this issue is addressed, players can capitalize on the current pandemic and expand their presence in the market.

The global medical clothing market is set to gain momentum from the rising incidence of hospital-acquired infections. Besides, the rising awareness campaigns regarding the benefits of clinical clothing would affect the market positively. Fortune Business Insights™ provided this information in a recent report, titled, “Medical Clothing Market Size, Share & Industry Analysis, By Product (Surgical Drapes, Medical Scrubs and Gowns, Gloves, Facial Protection, Sterilization Wraps, Protective Apparels and Others), By Application (Hospitals & Physicians’ Offices, Outpatient Facilities, and Others), and Regional Forecast, 2020-2027.” The report further states that the medical clothing market size was USD 63.3 billion in 2019 and is projected to reach USD 99.9 billion by 2027, exhibiting a CAGR of 5.9% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/medical-clothing-market-102704

Fortune Business Insights™ lists out the names of organizations present in the global market. They are as follows:

• Cardinal Health, Inc.
• Halyard Health
• 3M Company
• Medline Industries, Inc.
• Superior Uniform Groups
• Semperit AG Holding
• Ansell Healthcare LLC
• Medline Industries
• Mölnlycke Health Care
• Barco Uniforms
• Other prominent players

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-clothing-market-102704

Regional Analysis-

North America to Remain at the Forefront Stoked by Developed Healthcare Infrastructure

The market is geographically fragmented into the Middle East and Africa, Europe, Latin America, Asia Pacific, and North America. Amongst these, North America procured USD 25.5 billion in 2019 and is set to dominate in the forthcoming period. This growth is attributable to the presence of numerous medical clothing manufacturing companies, increasing prevalence of acute and chronic diseases, and developed healthcare infrastructure. Asia Pacific, on the other hand, is estimated to grow rapidly by exhibiting high CAGR on account of the increasing awareness programs amongst the masses regarding hygiene and safety.

Competitive Landscape-

Key Companies Focus on Acquiring Other Enterprises to Strengthen Position

Various big, small, and medium companies operating in the market are engaging in mergers and acquisition strategy to gain the maximum share and expand their businesses. It is also helping them in catering to the need of their growing consumer bases. Below are a couple of the latest key industry developments:

• November 2019: Ansell Limited teamed up with ProGlove to develop hand protection solutions by using innovative technology. It would enable the right personal protective equipment (PPE) compliance at the workplace.
• November 2018: Superior Uniform Group, Inc. successfully acquired CID Resources Inc. to gain ownership of the rising medical clothing providers and enter into a new segment in the uniform market.

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study. The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614

List of the companies functioning in the global market are

• LFB
• Shire
• Japan Blood Products Organization
• Biotest AG
• Grifols, S.A.
• C. Pharma (Green Cross Corporation)
• Octapharma
• Sanquin
• Kedrion S.p.A.
• Baxter
• China Biologic Products
• CSL
• Shanghai RAAS Blood Products

Get Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/plasma-fractionation-market-101614

Key Segmentation:

By Product Type

• Albumin
• Immunoglobulin
• Intravenous Immunoglobulin
• Subcutaneous Immunoglobulin
• Coagulation Factors
• Factor IX
• Factor VIII
• Prothrombin Complex Concentrates
• Fibrinogen concentrates
• Others
• Protease Inhibitors
• Others

By Application

• Immunology & Neurology
• Hematology
• Critical Care
• Pulmonology
• Others

By End User

• Hospitals & Clinics
• Clinical Research Laboratories
• Others (Academic Institutes, etc.)

By Geography

• North America (USA and Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
• Latin America (Brazil, Mexico and Rest of Latin America)
• Middle East & Africa (GCC, South Africa and Rest of Middle East & Africa)

Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for Market

The rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation. This is a major factor boosting the overall market. In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market. Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market.

However, high cost of fractionation and insufficient reimbursement policies may cause hindrance to the growth of the market. This, accompanied by the emergence of recombinant alternatives may hamper the market in the long run.

According to the report, the global market for plasma fractionation is estimated to rise at a CAGR of 6.2% and reach a value of US$ 38,652.1 Mn by 2026 from US$ 24,078.5 Mn in 2018. In terms of product, the market is anticipated to be dominated by the immunoglobulin segment as they play a major role in detecting and destroying the bacteria present in the body. In the year 2018, immunoglobulin segment accounted for about 47.7% share in the global market. On the other side, the protease inhibitors segment is anticipated to exhibit the growth at the fastest rate. This is attributable to the fact that protease inhibitors are used as antiviral agents and help to prevent infection. In addition to that, the use of these inhibitors for HIV is anticipated to drive the over the forecast period.